These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 6114725

  • 1. Long-term treatment of hyperlipoproteinemia with etofibrate: clinical observations.
    Kaffarnik H, Schneider J, Schubotz R, Zöfel P, Hausmann L, Goebel KM.
    Artery; 1980; 8(6):537-46. PubMed ID: 6114725
    [Abstract] [Full Text] [Related]

  • 2. [Longterm therapy and etofibrate (author's transl)].
    Kaffarnik H, Schneider J, Schubotz R, Zöfel P.
    MMW Munch Med Wochenschr; 1980 Jan 18; 122(3):95-8. PubMed ID: 6767931
    [Abstract] [Full Text] [Related]

  • 3. [The therapeutic efficacy of bezafibrate in hyperlipoproteinemias of various types].
    Noseda G, Fragiacomo C, Weidmann P, Bachmann C.
    Schweiz Med Wochenschr; 1980 Dec 06; 110(49):1875-7. PubMed ID: 7455660
    [Abstract] [Full Text] [Related]

  • 4. Clinical experience with bezafibrate.
    Schubotz R, Schneider J, Hausmann L, Mühlfellner G, Mühlfellner O, Kaffarnik H.
    Artery; 1980 Dec 06; 8(6):553-9. PubMed ID: 7259534
    [Abstract] [Full Text] [Related]

  • 5. [The range and lipid-lowering effect of etofibrate as a retard-preparation in patients with hyperlipoproteinemia type IIa (author's transl)].
    Mertz DP, Loewer H, Suermann I.
    Med Klin; 1979 Dec 21; 74(51-52):1953-6. PubMed ID: 542179
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Bile lipid composition in subjects with blood lipid disorders (types II and IV). Effect of a new hypolipemic drug (Etofibrate)].
    Altomonte L, Mingrone G, Ghirlanda G, Manna R, Rebuzzi A, Pala MA, Greco AV.
    Minerva Med; 1980 Feb 11; 71(4):273-8. PubMed ID: 7354946
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Therapy of hyperlipoproteinemia type IIa, IIb and IV with Etofibrate retard].
    Schwartzkopff W, Schilling A, Calder D.
    Med Welt; 1980 Apr 04; 31(14):515-20. PubMed ID: 7374415
    [No Abstract] [Full Text] [Related]

  • 11. [Effect of bezafibrate on lipid and apoprotein levels in patients with idiopathic hypertriglyceridemia].
    Naruszewicz M, Nowicka G, Szostak WB, Kłosiewicz-Latoszek L.
    Kardiol Pol; 1982 Apr 04; 25(7-8):527-31. PubMed ID: 7169740
    [No Abstract] [Full Text] [Related]

  • 12. [Etofibrate in severe diet-refractory cases of hyperlipoproteinemia].
    Schatton W, Holm E.
    Fortschr Med; 1986 Apr 03; 104(13):280-2. PubMed ID: 3699655
    [No Abstract] [Full Text] [Related]

  • 13. [Double-blind study of the therapeutic activity of a new hypolipemic drug: etofibrate].
    Altomonte L, Mingrone G, Negrini A, De Cunto F, Greco AV.
    Clin Ter; 1981 Jan 15; 96(1):31-8. PubMed ID: 7016409
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [A comparison of bezafibrate and clofibrate in type II B and type IV hyperlipoproteinemia].
    Bolzano K, Krempler F, Schellenberg B, Schlierf G.
    Acta Med Austriaca; 1979 Jan 15; 6(3):90-4. PubMed ID: 547652
    [Abstract] [Full Text] [Related]

  • 17. Pirifibrate in the treatment of hyperlipoproteinemia: types IIa, IIb, and IV.
    Lopez Rodriguez J, Martorell J.
    Clin Ther; 1980 Jan 15; 3(4):234-41. PubMed ID: 7273061
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Regression of hard exudates in diabetic background retinopathy in therapy with etofibrate antilipemic agent].
    Freyberger H, Schifferdecker E, Schatz H.
    Med Klin (Munich); 1994 Nov 15; 89(11):594-7, 633. PubMed ID: 7815987
    [Abstract] [Full Text] [Related]

  • 20. [Atherosclerosis treatment with etofibrate retard. New perspectives].
    Degenring FH, Schatton W, Hotz W.
    Fortschr Med; 1983 Aug 11; 101(30):1391-6. PubMed ID: 6618402
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.